MDRX on NASDAQ

Allscripts

American company

Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.) is a publicly traded American company that provides physician practices, hospitals, and other healthcare providers with practice management and electronic health record (EHR) technology. Veradigm also provides products for patient engagement and care coordination, as well as financial and analytics technology. The company has more than 180,000 physician users and has products in 2,700 hospitals and 13,000 extended care organizations.2 Its shares trade on NASDAQ under the symbol MDRX.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerMDRX on NASDAQ1
  • Industryhealth informatics, information technology1
  • HeadquartersChicago1
  • Websitewww.allscripts.com

Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.) is a publicly traded American company that provides physician practices, hospitals, and other healthcare providers with practice management and electronic health record (EHR) technology. Veradigm also provides products for patient engagement and care coordination, as well as financial and analytics technology. The company has more than 180,000 physician users and has products in 2,700 hospitals and 13,000 extended care organizations. The company formally changed its name from Allscripts to Veradigm in January 2023.2

The story

Allscripts was founded in 1981 and is headquartered in Chicago, Illinois. An additional key operations' office is located in Raleigh, North Carolina.

In 2008, Allscripts merged with the healthcare systems operations of its rival, Misys. In 2010, Allscripts-Misys merged with another healthcare information technology competitor, Eclipsys, in a $1.3 billion deal, merging patient records, to create the industry's largest network of clients.

In 2015, Allscripts acquired the California medical billing company CHMB Inc. 2017, Allscripts acquired the patient-engagement assets of NantHealth.

Allscripts acquired McKesson's healthcare IT business on August 3, 2017.[1], which included McKesson properties such as Per-Se Technologies, Enterprise Solutions, and HBO & Company.

In 2020 Allscripts executed two major divestment moves. In October, Allscripts sold its EPSi business, a provider of financial decision support and planning tools for hospitals and health systems, to Strata Decision Technology for $365 million. Later, in December 2020, Allscripts closed the sale of its care coordination business, CarePort Health, to Wellsky for $1.35 billion.

On January 3, 2023, Allscripts announced a corporate name change to Veradigm.

On February 29, 2024 Veradigm was suspended from the Nasdaq Stock Market due to non-compliance with listing rules. The company had failed to file its Annual Report for the year ended December 31, 2022 or its Quarterly Reports on for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023. The Company was also noncompliant with Nasdaq Listing Rules requiring companies listing common stock to hold an annual meeting of stockholders no later than one year after the end of the company’s fiscal year.

From Wikipedia’s article on Veradigm, shared under CC BY-SA 4.0.3

Acquisitions

In March 2013, Allscripts acquired dbMotion, Ltd., a developer of system interfaces and data analytics tools, and Jardogs LLC, a developer of a personal health record.

In July 2014, Allscripts acquired the London-based Oasis Medical Solutions to incorporate its leading Patient Administration System into its Allscripts Sunrise clinical system to make a single Electronic Patient Record solution.

In 2018 Allscripts acquired Practice Fusion.

In 2019, Allscripts acquired ZappRx, a Boston-based prescription drug startup, which provides an online platform used by patients, physicians, and pharmacists for the management of specialty medications.

From Wikipedia’s article on Veradigm, shared under CC BY-SA 4.0.3

Timeline

  1. Jul 23, 1999Went public Listed on NASDAQ1

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Huntington National Bank1$50.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3